Skip to main content
Fig. 2 | Virology Journal

Fig. 2

From: Development of a neutralization monoclonal antibody with a broad neutralizing effect against SARS-CoV-2 variants

Fig. 2

Effect of SKAI-DS84 on SARS-CoV-2 pseudo-particle neutralization. Dose–response curves were generated by measuring the relative luciferase activities of SARS-CoV-2 WT and seven variants of pseudovirus-infected hACE-Huh7 cells treated with increasing concentrations of a SKAI-DS84 and b bamlanivimab for 72 h. WT, wild-type; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2. *P < 0.05, **P < 0.01, significantly different from control

Back to article page

Virology Journal

ISSN: 1743-422X